Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.

Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.
复制标题

DOI:
10.1016/j.drup.2008.09.002
复制
发表时间:
2008-12
影响因子:
24.3
通讯作者:
Gabrilovich, Dmitry
Gabrilovich, Dmitry
中科院分区:
医学1区
文献类型:
--
作者:
Nefedova, Yulia;Gabrilovich, Dmitry

文献摘要

参考文献

被引文献

相似文献

Notch信号传导的激活已经涉及各种血液肿瘤的发病机制,包括白血病、淋巴瘤和多发性骨髓瘤。临床前研究表明,抑制Notch可能是治疗血液恶性肿瘤的一种有吸引力的新方法。这篇综述讨论了该领域的最新发现和Notch信号作为治疗靶点的潜在作用,重点是γ-分泌酶抑制剂的作用。
Activation of Notch signaling has been implicated in pathogenesis of various hematologic tumors including leukemias, lymphomas, and multiple myeloma. Pre-clinical studies have suggested that inhibition of Notch could be an attractive new approach to treatment of hematologic malignancies. This review discusses most recent findings in the field and potential role of Notch signaling as a therapeutic target focusing on the effects of γ-secretase inhibitors.
DOI: 10.1038/sj.onc.1208783
发表时间: 2005-09-22
期刊: ONCOGENE
影响因子: 8
作者:
Curry, CL;Reed, LL;Foreman, KE
通讯作者: Foreman, KE
DOI: 10.1080/10428190600773339
发表时间: 2006-11-01
影响因子: 2.6
作者:
Fu, Lu;Kogoshi, Hanae;Tohda, Shuji
通讯作者: Tohda, Shuji
DOI: 10.1016/s0092-8674(00)80336-0
发表时间: 1997-07-25
期刊: CELL
影响因子: 64.5
作者:
Blaumueller, CM;Qi, HL;ArtavanisTsakonas, S
通讯作者: ArtavanisTsakonas, S
DOI: 10.1182/blood-2003-07-2254
发表时间: 2004-05-01
期刊: BLOOD
影响因子: 20.3
作者:
Jundt, F;Pröbsting, KS;Dörken, B
通讯作者: Dörken, B
DOI: 10.1016/0092-8674(91)90111-b
发表时间: 1991-08-23
期刊: CELL
影响因子: 64.5
作者:
ELLISEN, LW;BIRD, J;SKLAR, J
通讯作者: SKLAR, J